Diagnosis and Management
This patient has acute bacterial rhinosinusitis (ABRS) and should be started on amoxicillin 500mg three times daily for 10-14 days, as the combination of purulent nasal discharge, photophobia with conjunctival injection, and symptoms persisting for 3 days meets criteria for bacterial superinfection. 1, 2
Clinical Diagnosis
The presentation strongly suggests ABRS based on several key features:
- Purulent nasal discharge (greenish mucus in one nare) combined with unilateral symptoms (right-sided congestion) and conjunctival erythema with photophobia indicates bacterial infection rather than simple viral URI 3, 2
- The failure to improve with OTC medications after 3 days of symptoms, while brief, combined with purulent features suggests progression from viral to bacterial infection 3, 1
- Erythematous oropharynx with cobblestoning indicates postnasal drainage from infected sinuses 3
- The right eye findings (erythema, photophobia without discharge) likely represent reactive conjunctivitis from adjacent sinus inflammation rather than primary conjunctivitis, given the unilateral nature matching the affected sinus side 3
Why Antibiotics Are Indicated Now
While guidelines typically recommend waiting 10 days for persistent symptoms, this patient meets alternative criteria for immediate antibiotic therapy:
- Purulent nasal discharge with localized symptoms (unilateral sinus congestion, ipsilateral eye involvement) suggests bacterial rather than viral etiology 3
- The combination of purulent rhinorrhea and facial/periorbital symptoms are key indicators that correlate with bacterial disease 2
- Failure of symptomatic treatment after 3 days with purulent features warrants antibiotic consideration rather than continued observation 3, 1
First-Line Treatment
Amoxicillin is the appropriate first-line antibiotic:
- Dosing: 500mg three times daily (or high-dose 875mg twice daily) for 10-14 days 1, 2, 4
- Rationale: Amoxicillin is effective against the most common pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis), is inexpensive, and well-tolerated 1, 5, 6
- Expected response: Patient should improve within 3-5 days 1, 2
Adjunctive Symptomatic Management
In addition to antibiotics, provide symptomatic relief:
- Intranasal corticosteroids (e.g., fluticasone, mometasone) to reduce mucosal inflammation and promote drainage 3, 2
- Saline nasal irrigation to help clear secretions 2, 4
- Analgesics (acetaminophen or ibuprofen) for pain management 1, 4
- Oral decongestants (pseudoephedrine) may provide additional symptomatic benefit, though evidence is limited 3, 2
Follow-Up and Treatment Failure
Reassess in 3-5 days:
- If no improvement or worsening, switch to amoxicillin-clavulanate 875mg/125mg twice daily or high-dose formulation (2000mg/125mg twice daily) to cover beta-lactamase producing organisms 1, 2, 5
- Alternative second-line agents include cefuroxime, cefpodoxime, or respiratory fluoroquinolones (levofloxacin, moxifloxacin) 3, 5, 6
- For penicillin allergy: Use respiratory fluoroquinolones or azithromycin, though macrolide resistance is increasing 1, 5, 6
Critical Red Flags to Monitor
Instruct the patient to return immediately if any of these develop:
- Orbital complications: Worsening eye pain, diplopia, vision changes, proptosis, or periorbital swelling 3
- Intracranial extension: Severe headache, altered mental status, focal neurologic signs, or high fever 3, 4
- Frontal bone swelling (Pott's puffy tumor) 3
These complications, while uncommon, can cause significant morbidity and mortality and require urgent imaging (CT) and possible hospitalization 3, 4
Imaging Not Indicated
Do not obtain imaging (plain films or CT) at this time:
- Imaging is not recommended for uncomplicated acute sinusitis as it does not change management and has high false-positive rates 3, 2, 4
- Up to 87% of healthy individuals recovering from viral URIs show sinus abnormalities on imaging 3
- Reserve CT for suspected complications, treatment failure after 21-28 days, or recurrent/chronic sinusitis requiring anatomic evaluation 1, 4